Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients

xlomafota13 shared this article with you from Inoreader Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients Via Experimental Dermatology Abstract We recently observed 39 patients in Italy presenting with telogen effluvium, including 7 patients with severe trichodynia. These include 9 men and 30 women ageing 48 to 73 years (mean age 64.6). In 16 patients, COVID‐19 presented with severe interstitial pneumonia, requiring hospitalization and Continuous Positive Airway Pressure (CPAP) therapy. Medications included paracetamol (39) systemic steroids ( 25) anticoagulants (16). Symptoms developed eight weeks to three months after clinical manifestations COVID‐19. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.